Treatment of dystonia in extensor hallucis longus and digitorum muscles with neurotomy of the branches of the deep fibular nerve: Preliminary results  by Allart, E. et al.
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Introduction:  Dystonia  in extensor  hallucis  and/or  digitorum  muscles  can  be observed  in  pyramidal  and
extrapyramidal  lesions  and  results  in  pain  in  these  toes,  spontaneous  or  when  walking,  problems  and
discomfort  when  putting  on shoes  and  socks,  and  cutaneous  lesions  on the  toes.  The  objective  of  this  study
was  to assess  the efﬁcacy  and  safety  of deep  ﬁbular  nerve  neurotomy  for the  extensor  hallucis  longus
(EHL)  and/or  the  extensor  digitorum  longus  (EDL)  branches  in  the treatment  of extension  dystonia  of  the
hallux  and/or  other  toes.
Patients  and methods:  A  deep  ﬁbular  nerve  neurotomy  was  performed  in  20 patients  (n  =  19 for  the
EHL,  n =  6  for  the  EDL).  We  retrospectively  analyzed  the  treatment’s  efﬁcacy  and  safety  and  assessed
the  patients’  self-reported  improvement  and  overall  treatment  satisfaction.
Results:  Dystonia  totally  disappeared  in  15  cases  (75%);  it persisted  at a  minimal  level  in the  other  patients.
The  patients  reported  a decrease  in  pain  (P <  0.01)  and fewer  difﬁculties  putting  on  shoes  and  socks
(P  <  0.001)  and  had  a high  median  level  of  satisfaction  (8.5/10).  Adverse  effects  were  rare  and  transient.
The  identiﬁcation  of  the  nerve  branches  was  sometimes  difﬁcult.
Discussion:  Deep  ﬁbular  nerve  neurotomy  for the  EHL and/or  EDL  branches  seems  to  be an  effective
treatment  for  extension  dystonia  of  the  hallux and/or  other  toes  and  its  consequences  for  the adult  neu-
rological  patient.  However,  these  encouraging  preliminary  results  should  be conﬁrmed  by  prospective,
longer-term  studies.
Level of evidence:  IV.
© 2015  Elsevier  Masson  SAS.  All  rights  reserved.. Introduction
Extension dystonia of the hallux and/or toes is a classical defor-
ity [1], encountered in two distinct contexts: extrapyramidal
eformity [2] and pyramidal lesions secondary to neonatal or
cquired brain injury [1,3]. It is related to hypertonia of the exten-
or hallucis longus (EHL) and/or the extensor digitorum longus
EDL) muscles. These extension spasms can lead to troublesome
ymptoms such as spontaneous or induced pain (either on the
orsal side of the toe(s) or of their tendon, which, when under
ension, can become painful), problems putting on shoes and
∗ Corresponding author.
E-mail address: etienne.allart@chru-lille.fr (E. Allart).
http://dx.doi.org/10.1016/j.otsr.2015.01.006
877-0568/© 2015 Elsevier Masson SAS. All rights reserved.socks, discomfort when wearing shoes, cutaneous lesions on the
dorsal side of the hallux [3–7], as well as problems when walking
related to the pain induced and to the instability that can occur at
the end of the stance phase [3,5,6].
The hyperextension mechanism always involves the EHL and/or
the EDL, which can be hypertonic, retracted, or both. In its isolated
form, this deformity involves hyperextension of the metatarsopha-
langeal (MTP) and the interphalangeals (IPs). If it is associated with
tension on the ﬂexor system, it often presents as hyperextension of
the MTP  and ﬂexion of the IPs. Hyperactivation of the EHL and/or
the EDL ﬁrst of all can be caused by true dystonia of these mus-
cles. When it occurs in the swing phase, it can also be related to
a tenodesis effect on the EHL and/or the EDL when the foot drops
because of a deﬁcit in the levator muscles. Finally, it can corre-
spond to an attempt to compensate for weakness in the anterior
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ibialis anterior muscle by the extensor digitorum muscles, which
re accessory dorsal ﬂexors. In these three cases, the severity of
he hyperextension can be aggravated by retraction of the muscles
nvolved.
Over the past few years, botulinum toxin treatment (BT) has
roved to be effective in treating dystonia of the EHL in extrapyra-
idal lesions such as after an acquired brain injury [3–5]. However,
his treatment often requires high doses of BT [5], limiting its
se in other hypertonic muscle groups, and necessitates repeated
njections. Neuro-orthopaedic treatment aims to prevent these two
itfalls. Lengthening the EHL tendon at the muscle–tendon junction
s a therapeutic possibility [8,9], all the more indicated in isolated
yperactivity of the extensor muscles when muscle retraction is
resent, even though to our knowledge the literature reports no
peciﬁc data on neurological hyperextension of the toes concerning
his technique, nor any description of EDL lengthening procedures.
n our experience, toe tendon lengthening procedures tend to give
nconsistent and transient results, and the degree of lengthening is
ften difﬁcult to predict (and is therefore a source of under- or over-
orrection). As for other locations, neurotomies have been shown to
e effective in treating muscular hypertonia associated with pyra-
idal syndrome [10]. We  have developed a selective neurotomy
echnique of the motor branches of the deep ﬁbular nerve (for-
erly referred to as the anterior tibial nerve) leading to the EHL
nd the EDL muscles.
In the present study, we analyzed the efﬁcacy and safety of deep
bular nerve neurotomy in adult patients suffering from disabling
xtension dystonia of the hallus and/or the other toes.
. Patients and methods
.1. Patients
In this preliminary open multicenter study, we included patients
resenting with dystonia in of the hallux and/or other toes, caus-
ng problems (pain, cutaneous lesions on the toes, problems putting
n shoes and socks, discomfort when walking), for which surgical
reatment had been recommended during a multidisciplinary con-
ultation. This consultation, which grouped physicians in physical
nd rehabilitation medicine, orthopaedic surgeons, and a neuro-
urgeon, allowed us to analyze the impact of dystonia of the toes,
o select the targets that should proﬁt from neurotomy (EHL and/or
he EDL), and obtain the patient’s informed consent. We  included
atients whatever the source of the dystonia, excluding patients
uffering from severe language or psychiatric disorders because
hey would have been unable to take part in a subsequent telephone
nterview. The study was conducted in compliance with the princi-
les of the Declaration of Helsinki and the patients were requested
o provide oral consent to participate in the study.
Deep ﬁbular nerve neurotomy was performed in 20 patients
etween July 2011 and January 2013 (Table 1). Twelve (60%) were
emale, and the median age was 52 years (range, 27–64 years). They
uffered from stroke (14 patients, 70%), traumatic brain injury (two
atients, 10%), cerebral palsy (one patient), craniostenosis (one
atient), primary generalized dystonia (one patient), and cerebro-
endinous xanthomatosis (one patient). For acquired lesions, the
edian duration was 9.5 years (range, 2.2–23.1 years). Six patients
30%) had been treated with BT for dystonia of the EHL, with at least
artial efﬁcacy for ﬁve of them.
.2. TreatmentNeurotomy for ﬁbular nerve branches that innervate the EHL
nd/or the EDL was performed under general anesthesia, with the
atient in the supine position. A vertical cutaneous incision on theSurgery & Research 101 (2015) 341–344
anterolateral side of the leg provided access to the space separat-
ing the tibialis anterior medially and the EHL and EDL laterally,
making it possible to ﬁrst approach the deep ﬁbular nerve trunk
and to repair the motor branches for both muscles. There was
always a common branch for the EHL and EDL, and a varying num-
ber of additional branches for each of the muscles (from one to
three) [11]. Since the course of the nerve varies between patients,
selective fascicular electrical neurostimulation was used to identify
motor branches and avoid sensory branches. Once they had been
identiﬁed, the muscular branches were resected from three-ﬁfths
to four-ﬁfths over a distance of 1 cm [12], such that the muscle
response to upstream electrical stimulation was clearly reduced.
The neurotomy targeted the EHL branches for 14 patients (70%),
the EDL alone for one patient (5%), and both for ﬁve patients (25%)
(Table 1). It was bilateral in two patients (for the EHL in one case and
the EDL in the other). The median follow-up period was 9.5 months
(range, 3–21 months). In most cases, the patients underwent other
therapeutic procedures in the same surgical time: one tibial nerve
neurotomy for the gastrocnemius, the soleus, and tibialis posterior
was done in three patients (15%), tendon lengthening in 16 patients
(80%), which in 11 (55%) involved the Achilles tendon, 11 the ﬂexor
hallucis longus, and 12 the ﬂexor digitorum longus (tenotomy). Two
patients (10%) underwent split tibialis anterior transfer, and three
(15%) a subtalar arthrodesis.
2.3. Evaluations
A retrospective study was ﬁrst conducted by comparing the
pre- and postoperative consultation data (carried out between 3
and 6 months after the procedure). The location of the dystonia
was recorded (hallux, other toes, or both), its severity (0 = absent,
1 = minimal, 2 = moderate, 3 = severe, based on its amplitude and
the frequency with which it occurred), its triggering features (per-
manent or initiated when standing or walking), the problem(s)
occurring in both passive functions (spontaneous pain in the dorsal
side of the toes or the extensor tendons, problems and discomfort
when putting on shoes and socks, toe calluses and ulcers) and when
walking (pain). In addition, intra- and postoperative adverse events
were systematically recorded.
In the second part of the study, all patients were contacted
by telephone in May  2013 by two  investigators who were not
members of the surgical team (CR and EA) to assess the self-
reported changes induced by the neurotomy. The patients were
ﬁrst requested to evaluate their main dystonia-induced complaint
before surgery (among those listed above) and to score the over-
all impairment related to the dystonia when standing and walking
before and after the procedure on a numeric scale (from 0 = no
impairment to 10 = major impairment). In addition, they were
asked to assess the changes over time in dystonia-induced impair-
ment on the Global Assessment Scale (GAS) [13], which uses a Likert
scale from −4 (major deterioration) through 0 (no change) to 4
(major improvement). Finally, the patients were requested to esti-
mate their overall satisfaction with the treatment of the EHL and/or
the EDL dystonia using a numeric scale (from 0 = not satisﬁed at all
to 10 = very satisﬁed).
2.4. Statistical analysis
Continuous variables were expressed as median and range, the
ordinal variables as median and interquartile interval. The preop-for the qualitative variables and a Wilcoxon test for the quantita-
tive variables. The signiﬁcance threshold was set at 0.05 (bilateral
signiﬁcance). The statistical analyses were performed using SPSS
software (version 20, SPSS Inc., Chicago, IL, USA).
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Table  1
Description of the population.
Patient Age (years) Gender Diagnosis Time since lesion (years) Treatment Side Follow-up period (months)
1 52 F Stroke 23.1 EHL Left 20
2  64 M Stroke 5.6 EHL Left 14
3  54 F Stroke 9.6 EHL Left 14
4  49 M Stroke 1.9 EHL Left 14
5  35 F Stroke 21.6 EHL Left 14
6  63 F Stroke 12.8 EHL + EDL Left 11
7  61 F Stroke 8.2 EHL + EDL Left 10
8  45 M Stroke 2.9 EDL Right 10
9  60 M Stroke 2.2 EHL Left 9
10  52 M Stroke 5.1 EHL Left 8
11  49 F Stroke 2.9 EHL Left 8
12  57 F Stroke 8.8 EHL Left 5
13  59 F Stroke 13.4 EHL Left 4
14  58 M Stroke 3.6 EHL Right 3
15  54 M TBI 10.0 EHL + EDL Left 11
16  46 F TBI 21.2 EHL + EDL Left 3
17  27 M Cerebral palsy – EHL Right 7
18  39 F Cerebrotendinous xanthomatosis – EHL + EDL Bilateral 3
19  52 F Craniostenosis – EHL Left 12
20  37 F Generalized dystonia – 
F: female; M:  male; TBI: traumatic brain injury; EHL: extensor hallucis longus; EDL: exten
Table 2
Pre-/postsurgery changes in the severity of dystonia and its triggering features
(based on clinical examination, retrospective).
Preop Postop
Triggering features
Permanent 2 (10.5%) 0
Triggered 18 (90%) 5 (25%)
When standing 12 (60%) 2 (10%)
When walking 18 (90%) 3 (15%)
Dystonia severity
Mild 3 (15%) 5 (25%)
Moderate 13 (65%) 0
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tive adverse event. One patient presented a delay in healing (< 2
months) and three patients (15%) reported transient neurogenic
pain (lasting no more than 6 weeks) or dysesthesia of the dorsum of
the foot or around the surgical scar. In addition, the procedure was
Table 4Severe 4 (20%) 0
ata are the number of patients (%). Postop: 3–6 months after procedure.
. Results
.1. Symptoms and data from the clinical examination
Data showing the change over time in the dystonia’s severity and
riggering features are summarized in Table 2. Before the surgery,
ystonia most often triggered when standing or walking, it was
ermanent in two cases of dystonia of the EHL. The clinical severity
f the dystonia was moderate to severe in most cases. None of the
atients presented contracture of the EHL and/or the EDL. After
reatment, complete disappearance of the dystonia was  observed
n 15 cases (75%), it persisted in ﬁve patients but always with mild
everity. No ﬂexion claw toes were observed after the surgery.
Deep ﬁbular nerve neurotomy was associated with a marked
eduction in the disabling consequences of dystonia identiﬁed prior
o treatment (Table 3). This was particularly true for the most fre-
uent complaints (spontaneous pain, difﬁculties and discomfort
utting on shoes and socks). All the patients could walk before the
able 3
re-/postsurgery changes in the disabling consequences of dystonia (based on data
n  medical records, retrospective).
Discomfort Preop Postop
Spontaneous pain 8 (40%) 1 (5%)
Pain  when walking 16 (80%) 1 (5%)
Difﬁculties/discomfort wearing socks/shoes 18 (90%) 3 (15%)
Cutaneous lesions 5 (25%) 1 (5%)
ata are the number of patients (%). Postop: 3–6 months after procedure.EHL Bilateral 8
sor digitorum longus.
procedure, which led to no notable change in walking conditions
(assistive devices, orthotics needs, shoes).
3.2. Subjective assessment
Before treatment, the patients’ main complaint related to their
dystonia was the difﬁculties and discomfort when putting on shoes
and socks (n = 11, 55%), pain in the toes involved in the dystonia
when standing or walking (n = 4, 20%), poor balance when walking
(n = 4, 20%), and spontaneous pain in the toes (n = 1).
After the intervention, the overall impairment related to stand-
ing and walking was substantially improved (P < 0.01 and 0.001,
respectively) (Table 4). Likewise, all the patients’ complaints were
relieved to a fair degree after surgery, notably for discomfort and
difﬁculties when putting on and wearing shoes and socks and pain
when walking. Only the improvement in cutaneous lesions on the
toes, although quantitatively high, remained nonsigniﬁcant. The
patients’ overall satisfaction with the treatment of dystonia of the
EHL and/or the EDL reached a median of 8.5 (range, 5–10).
3.3. Peri- and postoperative adverse events
Four patients (20%) presented a transient peri- or postopera-Changes in subjective evaluations of the different problems presented by the
patients, as related to the dystonia (data from telephone interview).
Preop Postop P
Overall impairment (0–10)
Standing 4 (8) 0 < 0.01
Walking 8 (3.25) 0.5 (1.25) < 0.001
Subjective changes (GAS −4; 4)
Spontaneous pain (n = 8) 3 (1) < 0.01
Pain when walking (n = 16) 3 (1) < 0.001
Difﬁculties/discomfort wearing
socks/shoes (n = 18)
3 (1) < 0.001
Cutaneous lesions (n = 5) 3 (3) 0.066
Data are median and interquartile interval values. GAS: Global Assessment Scale;
Postop: at the telephone interview (median, 9.5 months after the procedure [range,
3–21 months]).
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ot totally completed in three patients: all the branches could not
e repaired in two and in one the neurostimulator used was  defec-
ive. In this patient, the BT treatment had to be resumed. We noted
o deterioration of motor command of the dorsal ﬂexor muscles in
he postoperative period.
. Discussion
This study is the ﬁrst to evaluate the efﬁcacy and safety of deep
bular nerve neurotomy for the EHL and EDL in the treatment of
xtension dystonia of the hallux and the toes. The results of this
pen retrospective study seem to show substantial efﬁcacy in both
he clinical characteristics of dystonia (triggering features, sever-
ty) and its impact. Patient satisfaction was high. Adverse events
ere rare and transient, although the perioperative identiﬁcation
f nerve branches was sometimes difﬁcult.
The data from the current study on the impact of dystonia of the
HL and/or the EDL conﬁrm the data reported in the literature [3–5].
his was observed mainly on passive functions, i.e., in problems
utting on and wearing socks and shoes, spontaneous or walking-
nduced pain in the toes, and the onset of cutaneous lesions of the
oes. No data exist in the literature on the prevalence and effects of
DL dystonia. In our population, it was less frequent than dystonia
f the EHL and, in all but one case, the two were associated.
We  report a nearly 75% rate of complete disappearance of the
ystonia after neurotomy, whereas residual dystonia was always
ild. BT treatment improved the condition similarly, without nec-
ssarily complete disappearance [4]. The effects of dystonia on
utting on shoes and socks, pain, and walking were substan-
ially reduced, whether assessed by the examiner or the patient.
here was also improvement in cutaneous lesions, but it remained
onsigniﬁcant; this could be explained by the small number of
atients concerned and the fact that one patient had considerable
o-morbidities and retained cutaneous lesions despite the sub-
tantial efﬁcacy on the dystonia. We  consider that the patient’s
elf-assessment is an important part of the evaluation protocol. The
evel of patient satisfaction was high, even when an adverse effect
ccurred.
In our experience, deep ﬁbular nerve neurotomy for branches
eading to the EHL and/or the EDL is most often combined with a
oncomitant surgical procedure, or sometimes performed after the
reatment of a more global deformity of the distal extremity of the
ower limb, most often an equinovarus deformity. Only one patient
resenting with generalized dystonia was treated with deep ﬁbu-
ar neurotomy alone. As has been demonstrated for equinovarus
eformity, neuro-orthopaedic treatment (in particular neurotomy)
ives long-lasting, more effective results than BTI does [14–16]. It
lso allows one to save BT for other hypertonic muscles. This is par-
icularly pertinent for EHL dystonia, which is usually more severe
han dystonia of the upper limb [17] and requires high doses of BT
5].
Adverse effects occurred in 20% of the patients, but they were
lways transient and benign and did not impact the level of patient
atisfaction at the intermediate term. The fact that the procedure
ould not be completed in three patients reﬂects the difﬁculties
ossibly encountered in identifying the different motor branches
f the EHL and/or the EDL. Even though a common trunk for the
HL and the EDL is always present, up to three additional branches
ay  be present for each muscle, which could sometimes be difﬁcult
o identify. Precise, extensive dissection of the deep ﬁbular nerve is
herefore required, which leaves quite a long scar, and the patient
ust be advised of this.
This study suffers from a number of limitations. In addition to
ts retrospective design and the absence of a control group, the
[
[Surgery & Research 101 (2015) 341–344
study population was heterogeneous and included a high propor-
tion of patients with traumatic brain injuries compared to patients
presenting injury to the basal ganglia. Yet the physiopathology of
dystonia of the toes is not strictly identical in the two  cases [18],
which limits the extrapolation of the results. The subjectivity of the
evaluation criterion of frequency and severity of dystonic move-
ments can also be regretted, but today no speciﬁc tool adapted
to dystonia of the toes is available. Finally, given the relatively
short follow-up period, the long-term effects of deep ﬁbular nerve
neurotomy remains to be established, particularly given that the
physiopathology of toe dystonia is not identical to that commonly
seen in spasticity.
5. Conclusion
Deep ﬁbular nerve neurotomy of the branches leading to the
EHL and/or EDL could be of interest for relieving hyperextension
of the hallux and/or other toes and reducing the latter’s disabling
consequences. Adverse events were rare and transient, but identi-
ﬁcation of all the motor branches was sometimes difﬁcult. These
encouraging preliminary results must now be conﬁrmed in a large
long-term prospective study.
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